4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-021060
Director sold 6,800 shares at $81.97 ($557,396)
- Director acquired 6,800 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Foster-Cheek Kaye I Director | 2018-03-19 | Option exercise | +6,800 | $47.33 | $321,844 | 9,000 | D: show line 1 in the form |
| Foster-Cheek Kaye I Director | 2018-03-19 | Sale | −6,800 | $81.97 | $557,396 | 2,200 | D: show line 2 in the form |
| Open-market sales · 6,800 sh · avg $81.97 · $557,396 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Foster-Cheek Kaye I Director | 2018-03-19 | Option exercise · Stock option (right to buy) | −6,800 | 0 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…